SAN DIEGO, April 26, 2017 /PRNewswire/ -- Trovagene,
Inc. (NASDAQ: TROV), a precision medicine biotechnology company,
announced today that it will report financial results for the first
quarter ended March 31, 2017 on
Wednesday, May 10, 2017.
Trovagene's senior management team will host a conference call
on Wednesday, May 10, 2017 at
5:00 p.m. Eastern Daylight Time
(2:00 p.m. Pacific Daylight Time) to
discuss the results and update investors on the Company's
progress.
To access the conference call, please dial (888) 347-6081
(domestic), (412) 902-4285 (international), or (855) 669-9657
(Canada), conference ID# 10097532.
To access the telephone replay of the call, dial (877) 344-7529
(domestic), (412) 317-0088 (international), or (855) 669-9658
(Canada), replay ID# 10105678. The
replay will be available one hour after the conclusion of the call.
The webcast and telephone replay will be archived on the Company's
website following the conference at
http://trovagene.investorroom.com/events.
About Trovagene, Inc.
Trovagene is a precision medicine biotechnology company
developing oncology therapeutics for improved cancer care by
leveraging its proprietary Precision Cancer Monitoring® (PCM)
technology in tumor genomics. Trovagene has broad
intellectual property and proprietary technology to measure
circulating tumor DNA (ctDNA) in urine and blood to identify and
quantify clinically actionable markers for predicting response to
cancer therapies. Trovagene offers its PCM technology at its
CLIA/CAP – accredited laboratory and plans to continue to
vertically integrate its PCM technology with precision cancer
therapeutics. For more information, please
visit www.trovagene.com.
Trovagene Contact:
Vicki Kelemen
Sr. Director, Communications
858-952-7652
vkelemen@trovagene.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/trovagene-to-announce-first-quarter-2017-financial-results-and-host-conference-call-on-wednesday-may-10-2017-300445848.html
SOURCE Trovagene, Inc.